🌐 RTS,S malaria vaccine

organization

RTS,S malaria vaccine is a partially effective immunization developed by GlaxoSmithKline and the PATH Malaria Vaccine Initiative that became the first WHO-approved malaria vaccine and serves as a significant public health intervention monitored for deployment efficacy and disease burden reduction across endemic regions.

1
Signals
1
Articles

Linked Signals

SignalStatusLensRoleConfidenceLast Seen
WHO confirms malaria vaccine impact across Ghana, Kenya, Malawi active Health involved 97%